This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of single combined (long‐ or short‐acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma.
No takes yet. Share an insight, caveat, or question.
Crossingham et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: